Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.

Item
http://www.wikidata.org/entity/Q37627206
Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.Severity of Hypertension Correlates with Risk of Thromboembolic Stroke.Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD.Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study.Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults.Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.Prescription Patterns of Non-Vitamin K Oral Anticoagulants Across Indications and Factors Associated with Their Increased Prescribing in Atrial Fibrillation Between 2012-2015: A Study from the Norwegian Prescription Database.Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study).Stroke prevention strategies in North American patients with atrial fibrillation: the GLORIA-AF registry program.Uninterrupted Use of Oral Anticoagulants for the Ablation of Atrial Flutter: A Single Center Cohort of 154 Patients.Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter studyCost Saving Potential of an Early Detection of Atrial Fibrillation in Patients after ICD Implantation
P2860

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.

Item
http://www.wikidata.org/entity/Q37627206
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evolving antithrombotic treatm ...... diagnosed atrial fibrillation.
@en
Evolving antithrombotic treatm ...... diagnosed atrial fibrillation.
@nl
type
label
Evolving antithrombotic treatm ...... diagnosed atrial fibrillation.
@en
Evolving antithrombotic treatm ...... diagnosed atrial fibrillation.
@nl
prefLabel
Evolving antithrombotic treatm ...... diagnosed atrial fibrillation.
@en
Evolving antithrombotic treatm ...... diagnosed atrial fibrillation.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Evolving antithrombotic treatm ...... diagnosed atrial fibrillation.
@en
P2093
P2860
P304
P31
P356
10.1136/HEARTJNL-2016-309832
P407
P433
P478
P50
P577
P698
P921
P932